LON:SUMM

Summit Therapeutics (SUMM) Share Forecast, Price & News

GBX 20.50

0.00 (0.00%)

(As of 02/21/2020)

Compare

Today's Range: 18
▼
20.50
50-Day Range: 20.50
▼
20.50
52-Week Range: 18
▼
32.50

Volume: 280,318 shs
Average Volume: 382,504 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Headlines

About Summit Therapeutics (LON:SUMM) Stock

Summit Therapeutics plc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel medicines to treat rare and infectious diseases in the United Kingdom and North America. It is conducting clinical programmes focused on the genetic disease Duchenne muscular dystrophy (DMD) and the infectious disease Clostridium difficile infection (CDI). The company's lead DMD product candidate is ezutromid, an orally administered small molecule, which is in Phase II clinical trial; and lead CDI product candidate is ridinilazole, an orally administered small molecule antibiotic that has completed Phase II clinical trials. It has strategic alliance with the University of Oxford to develop utrophin modulators. The company was formerly known as Summit Corporation plc and changed its name to Summit Therapeutics plc in February 2015. Summit Therapeutics plc was founded in 2003 and is based in Abingdon, the United Kingdom.

SUMM Price History

30 days | 90 days | 365 days | Advanced Chart

SUMM Stock News Headlines

September 26, 2023 | finance.yahoo.com

Capstan Therapeutics to Participate in Upcoming Industry Conferences

September 21, 2023 | finance.yahoo.com

Leading Experts Join 7th Annual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer

September 27, 2023 | Edge On The Street (Ad)

Is Gold Really Boring?

Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.

September 20, 2023 | finance.yahoo.com

Sangamo Therapeutics to Present at the Jefferies Cell & Genetic Medicine Summit

September 18, 2023 | finance.yahoo.com

Avalyn Pharma’s CEO Leads Workshop on Clinical Strategy at IPF Summit

September 13, 2023 | finance.yahoo.com

Sling Therapeutics to Participate in the Stifel Virtual I&I Summit

September 8, 2023 | markets.businessinsider.com

Travere Therapeutics Joins American Kidney Fund’s 2023 Corporate Membership Program at ‘Champion’ Level

September 7, 2023 | msn.com

Resolution on unified health architecture likely at summit

September 27, 2023 | Edge On The Street (Ad)

Is Gold Really Boring?

September 7, 2023 | businesswire.com

Coya Therapeutics Successfully Engineers Regulatory T Cell (Treg) Derived Exosomes with CTLA-4 Protein to Selectively Target Immune Cells with Potential to Deliver Targeted ...

September 7, 2023 | businesswire.com

Vesigen Highlights New Data on Non-Viral Delivery Platform at the Exosome Based Therapeutic Development Summit

September 7, 2023 | finance.yahoo.com

ReCode Therapeutics to Present at September Investor Conferences

September 6, 2023 | bizjournals.com

$2M raise marks beginning of 'rapid' growth phase for this Santa Fe biotech startup

August 31, 2023 | benzinga.com

Akston Biosciences Receives 2023 Most Innovative Award at Animal Health Summit

August 30, 2023 | finanznachrichten.de

Akeso, Inc.: Akeso Announced 2023 Interim Results: First Profit, Growing Sales of PD-1/CTLA-4 Bispecific Antibody and Priority Review of PD-1/VEGF

August 28, 2023 | finanznachrichten.de

XNK Therapeutics AB: XNK Therapeutics to present at the 8th CAR-TCR Summit in Boston

August 28, 2023 | finance.yahoo.com

Abata Therapeutics to Present and Participate in Upcoming Investor and Industry Events

August 28, 2023 | benzinga.com

XNK Therapeutics to present at the 8th CAR-TCR Summit in Boston

August 24, 2023 | finance.yahoo.com

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023

August 22, 2023 | finance.yahoo.com

Medigene AG to present at the 8th CAR-TCR Summit in Boston

August 17, 2023 | finance.yahoo.com

CytoMed Therapeutics Limited to Present at the August 24th Virtual Investor Summit

August 16, 2023 | benzinga.com

Halia Therapeutics Opens the Doors of its New Headquarters and Laboratory Facilities in Lehi, Utah

August 11, 2023 | finanznachrichten.de

Trevi Therapeutics, Inc.: Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update

August 10, 2023 | msn.com

Maxion Therapeutics moves into The Works on Unity Campus

August 9, 2023 | msn.com

Summit Therapeutics GAAP EPS of -$0.02

August 3, 2023 | finance.yahoo.com

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results

July 25, 2023 | finance.yahoo.com

Combined Therapeutics to Present Multi-Organ Protection (MOP) mRNA Vaccine Platform at the 3rd mRNA-Based Therapeutics Summit

See More Headlines

Receive SUMM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Summit Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SUMM Company Calendar

Last Earnings: 6/12/2019
Today: 9/27/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Drugs - Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:SUMM
CUSIP: N/A
CIK: N/A
Web: www.summitplc.com
Phone: +44-1235-443939
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Glyn O. Edwards (Age 63)
CEO & Exec. Director

Mr. Erik Ostrowski (Age 46)
Chief Financial Officer

Prof. David Roblin (Age 53)
COO, Chief Medical Officer and Pres of R&D

Prof. Kay Davies (Age 69)
Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor

Ms. Michelle Avery
Director of Investor Relations

Key Competitors

View All Competitors

SUMM Stock - Frequently Asked Questions

How have SUMM shares performed in 2023?: Summit Therapeutics' stock was trading at GBX 20.50 at the beginning of the year. Since then, SUMM stock has increased by 0.0% and is now trading at GBX 20.50.
View the best growth stocks for 2023 here.
How were Summit Therapeutics' earnings last quarter?: Summit Therapeutics PLC (LON:SUMM) posted its earnings results on Wednesday, June, 12th. The company reported ($3.00) EPS for the quarter, topping analysts' consensus estimates of ($4.00) by $1.00.
What other stocks do shareholders of Summit Therapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Summit Therapeutics investors own include Summit Therapeutics (SMMT), American Airlines Group (AAL), Acadia Healthcare (ACHC), Diana Shipping (DSX), 2570 (JLF.L) (JLF), National Fuel Gas (NFG), Tailored Brands (TLRD), The Weir Group (WEIR) and Acacia Mining (ABGLF).

What is Summit Therapeutics' stock symbol?: Summit Therapeutics trades on the London Stock Exchange (LON) under the ticker symbol "SUMM."
How do I buy shares of Summit Therapeutics?: Shares of SUMM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Summit Therapeutics' stock price today?: One share of SUMM stock can currently be purchased for approximately GBX 20.50.
How can I contact Summit Therapeutics?: Summit Therapeutics' mailing address is 136A Eastern Avenue, ABINGDON, OX14 4SB, United Kingdom. The official website for the company is www.summitplc.com. The company can be reached via phone at +44-1235-443939.

This page (LON:SUMM) was last updated on 9/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial